Investor · 1 deal
Global Bio Fund
Disclosed deals
Every published round Global Bio Fund took part in, and every parcel of existing shares it bought off another holder. Deals we hold but haven't published yet are not counted.
| Company | Stage | Announced | Amount | Role | Alongside | Sources |
|---|---|---|---|---|---|---|
| Baymatob | Series A | 23 Mar 2022 | $4.6m | Lead | Alberts Impact Ventures, Alberts Impact Ventures portfolio (24 Nov 2022), Alberts Impact Ventures portfolio (23 Mar 2022) |
Portfolio
Companies Global Bio Fund has backed in a published round, and companies whose existing shares it bought off another holder.
| Company | What it does | First invested | Rounds | Led |
|---|---|---|---|---|
| Baymatob | Developing an AI-powered maternal and foetal health platform ('Oli') that provides early … | 23 Mar 2022, Series A | 1 | 1 |
Funds
Fund closes reported for Global Bio Fund, as distinct from the investments it has made.
Portfolio companies acquired
Companies Global Bio Fund has backed that another company then bought. An exit for the holding, not a deal Global Bio Fund did.
People
Coverage
Stories naming Global Bio Fund. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
No coverage collected yet.